tripotassium dicitrate bismuthate

DRUG2 trials

Sponsors

Seoul National University Bundang Hospital

Conditions

Helicobacter InfectionHelicobacter Infections

Phase 4

Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

CompletedNCT01792700

Seoul National University Bundang HospitalHelicobacter Infections

Start: 2003-01-31End: 2010-12-31Updated: 2013-02-15

Unknown Phase

The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

TerminatedNCT02359331

Seoul National University Bundang HospitalHelicobacter Infection

Start: 2014-08-31End: 2022-12-01Updated: 2023-04-13

Related Papers

Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.

2013-09-1915 citations